Pharmacoeconomics of Influenza Vaccination for Healthy Working AdultsReviewing the Available Evidence

被引：0
作者：
Maarten J. Postma
Paul Jansema
Marianne L. L. van Genugten
Marie-Louise A. Heijnen
Johannes C. Jager
Lolkje T. W. de Jong-van den Berg
机构：
[1] University of Groningen Research Institute of Pharmacy (GUIDE/GRIP),Groningen University Institute for Drug Exploration
[2] National Institute of Public Health and the Environment (RIVM),undefined
来源：
Drugs | 2002年 / 62卷
关键词：
Influenza; Indirect Cost; Influenza Vaccination; Indirect Benefit; Pharmacoeconomic Evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A favourable pharmacoeconomic profile has been well established for influenza vaccination in the elderly. For employers relevant benefits seem to exist for vaccinating healthy working adults to avert absenteeism and related production losses. From a pharmacoeconomic point of view it is relevant to consider whether societal benefits of vaccination for healthy working adults is worthwhile given the costs of vaccination for the community.
引用
收藏
页码：1013 / 1024
页数：11
相关论文
共 112 条
  • [1] Sullivan MS(1993)Estimates of the us health impact of influenza Am J Public Health 12 1712-6
  • [2] Monto AS(1998)Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Weekly Rep 47 1-26
  • [3] Longini IM(2000)Pharmacoeconomics of influenza vaccination in the elderly; reviewing the available evidence Drugs & Aging 17 217-27
  • [4] Postma MJ(2000)Lowering the age for influenza vaccination Am Fam Physician 61 2967-8
  • [5] Baltussen RMPM(1996)Emerging infections: pandemic influenza Epidemiol Rev 18 64-76
  • [6] Heijnen M-L(2000)Influenza after a Christmas dinner (Griep als toetje) [in Dutch] Infectieziekten Bulletin 11 161-4
  • [7] Raymond LW(2000)Economic evaluations of influenza vaccination in healthy working-age adults; employer and society perspective Pharmacoeconomics 18 173-83
  • [8] Glezen WP(1999)the socioeconomics of influenza and its control measures Pharmacoeconomics 16 1-100
  • [9] Bovée L(1996)The socioeconomics of influenza and influenza vaccination in europe Pharmacoeconomics 9 1-81
  • [10] Esman S(1976)The swine-influenza decision N Engl J Med 295 759-65
12345678910